Influence of 5-(3-chlorophenyl)-4-(4-methylphenyl)-2,4-dihydro-3H-1,2,4- triazole-3-thioneon the anticonvulsant action of 4 classical antiepileptic drugs in the mouse maximal electroshock-induced seizure model

Pharmacological Reports

Volumn 64, Issue 4, 2012, Pages 970-978

  Łuszczki, Jarogniew J ^a,b   Plech, Tomasz ^b   Wujec, Monika ^b  

^a INSTITUTE OF AGRICULTURAL MEDICINE   (Poland)

^b MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

Antiepileptic drugs; Maximal electroshock induced seizures; Pharmacokinetic pharmacodynamic interaction

Indexed keywords

5 (3 CHLOROPHENYL) 4 (4 METHYLPHENYL) 2,4 DIHYDRO 3H 1,2,4 TRIAZOLE 3 THIONE; CARBAMAZEPINE; PHENOBARBITAL; PHENYTOIN; TP 10; TRIAZOLE DERIVATIVE; UNCLASSIFIED DRUG; VALPROIC ACID;

ADULT ANIMAL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTICONVULSANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG BRAIN LEVEL; DRUG DOSE COMPARISON; DRUG POTENTIATION; DRUG STRUCTURE; ELECTRIC CURRENT; ELECTRIC SHOCK; ELECTRODE; ELECTROSTIMULATION; LONG TERM MEMORY; MALE; MOTOR PERFORMANCE; MOUSE; MOUSE STRAIN; MUSCLE STRENGTH; NEUROPROTECTION; NONHUMAN; SEIZURE; SEIZURE THRESHOLD; SKELETAL MUSCLE;

EID: 84867683430     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: 10.1016/S1734-1140(12)70893-9     Document Type: Article

References (23)

1. Boissier JR, Tardy J, Diverres JC: A simple novel method to explore tranquilizer activity: the chimney test (French). Med Exp (Basel), 1960, 3, 81-84.
2. Genovese S, Epifano F, Curini M, Dudra-Jastrzȩbska M, Łuszczki JJ: Prenyloxyphenylpropanoids as a novel class of anticonvulsive agents. Bioorg Med Chem Lett, 2009, 19, 5419-5422.
3. Litchfield JT, Wilcoxon F: A simplified method of evaluating dose-effect experiments. J Pharmacol Exp Ther, 1949, 96, 99-113.
4. Löscher W, Fassbender CP, Nolting B: The role of technical, biological and pharmacological factors in the laboratory evaluation of anticonvulsant drugs. II. Maximal electroshock seizure models. Epilepsy Res, 1991, 8, 79-94.
5. Löscher W, Fiedler M: The role of technical, biological, and pharmacological factors in the laboratory evaluation of anticonvulsant drugs. VII. Seasonal influences on anticonvulsant drug actions in mouse models of generalized seizures. Epilepsy Res, 2000, 38, 231-248.
6. Łuszczki JJ, Andres-Mach M, Cisowski W, Mazol I, Głowniak K, Czuczwar SJ: Osthole suppresses seizures in the mouse maximal electroshock seizure model. Eur J Pharmacol, 2009, 607, 107-109.
7. Łuszczki JJ, Andres-Mach M, Gleńsk M, Skalicka- Woźniak K: Anticonvulsant effects of four linear furanocoumarins, bergapten, imperatorin, oxypeucedanin, and xanthotoxin, in the mouse maximal electroshock-induced seizure model: a comparative study. Pharmacol Rep, 2010, 62, 1231-1236.
8. Łuszczki JJ, Antkiewicz-Michaluk L, Czuczwar SJ: Isobolographic analysis of interactions between 1-methyl-1,2,3,4-tetrahydroisoquinoline and four conventional antiepileptic drugs in the mouse maximal electroshock-induced seizure model. Eur J Pharmacol, 2009, 602, 298-305.
9. Łuszczki JJ, Cioczek JD, Kocharov SL, Andres-Mach M, Kominek M, Żółkowska D: Effects of three N-(carboxyanilinomethyl) derivatives of p-isopropoxyphenylsuccinimide on the anticonvulsant action of carbamazepine, phenobarbital, phenytoin and valproate in the mouse maximal electroshock-induced seizure model. Eur J Pharmacol, 2010, 648, 74-79.
10. Łuszczki JJ, Głowniak K, Czuczwar SJ: Imperatorin enhances the protective activity of conventional antiepileptic drugs against maximal electroshock-induced seizures in mice. Eur J Pharmacol, 2007, 574, 133-139. (Pubitemid 47575522)
11. Łuszczki JJ, Głowniak K, Czuczwar SJ: Time-course and dose-response relationships of imperatorin in the mouse maximal electroshock seizure threshold model. Neurosci Res, 2007, 59, 18-22. (Pubitemid 47285389)
12. Łuszczki JJ, Kocharov SL, Czuczwar SJ: Effect of p-isopropoxyphenylsuccinimide monohydrate on the anticonvulsant action of carbamazepine, phenobarbital, phenytoin and valproate in the mouse maximal electro-shock- induced seizure model. Pharmacol Rep, 2010, 62, 194-202.
13. Łuszczki JJ, Kocharov SL, Czuczwar SJ: N-(anilinomethyl)-p- isopropoxyphenylsuccinimide potentiates the anticonvulsant action of phenobarbital and valproate in the mouse maximal electroshock-induced seizure model. Neurosci Res, 2009, 64, 267-272.
14. Łuszczki JJ, Wojda E, Andres-Mach M, Cisowski W, Gleńsk M, Głowniak K, Czuczwar SJ: Anticonvulsant and acute neurotoxic effects of imperatorin, osthole and valproate in the maximal electroshock seizure and chimney tests in mice: a comparative study. Epilepsy Res, 2009, 85, 293-299.
15. Łuszczki JJ, Wojda E, Raszewski G, Głowniak K, Czuczwar SJ: Influence of imperatorin on the anticonvulsant activity and acute adverse-effect profile of lamotrigine in maximal electroshock-induced seizures and chimney test in mice. Pharmacol Rep, 2008, 60, 566-573.
16. Meyer OA, Tilson HA, Byrd WC, Riley MT: A method for the routine assessment of fore- and hindlimb grip strength of rats and mice. Neurobehav Toxicol, 1979, 1, 233-236. (Pubitemid 11204691)
17. 7 receptors affinity of 1-[(4-arylpiperazin-1-yl)-propyl]-succinimides. Pharmacol Rep, 2012, 64, 326-335.
18. Plech T, Wujec M, Siwek A, Kosikowska U, Malm A: Synthesis and antimicrobial activity of thiosemicarbazides, s-triazoles and their Mannich bases bearing 3-chlorophenyl moiety. Eur J Med Chem, 2011, 46, 241-248.
19. v7/KCNQ/M potassium channels. Curr Neurol Neurosci Rep, 2008, 8, 345-352.
20. Sałat K, Kulig K, Sałat R, Filipek B, Malawska B: Analgesic and anticonvulsant activity of new derivatives of 2-substituted 4-hydroxybutanamides in mice. Pharmacol Rep, 2012, 64, 102-112.
21. Stables JP, Kupferberg HJ: Chapter 16 - The NIH Anticonvulsant Drug Development (ADD) Program: preclinical anticonvulsant screening project. In: Molecular and Cellular Targets for Anti-epileptic Drugs. Eds. Avanzini G, Regesta G, Tanganelli P, Avoli M, John Libbey, London, 1997, 191-198.
22. Venault P, Chapouthier G, de Carvalho LP, Simiand J, Morre M, Dodd RH, Rossier J: Benzodiazepine impairs and β-carboline enhances performance in learning and memory tasks. Nature, 1986, 321, 864-866. (Pubitemid 16097728)
23. White HS, Woodhead JH, Wilcox KS, Stables JP, Kupferberg HJ, Wolf HH: Discovery and preclinical development of antiepileptic drugs. In: Antiepileptic Drugs, 5th edn., Eds. Levy RH, Mattson RH, Meldrum BS, Perucca E, Lippincott Williams & Wilkins, Philadelphia, 2002, 36-48.